Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Primary Neoplasm clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Primary Neoplasm: 1 US clinical trial tracked, none currently recruiting.

Primary Neoplasm is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Fox Chase Cancer Center, running 1 of these trials.

Enrollment posture brief

Registry condition primary-neoplasm

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Primary Neoplasm (this)0%
Open-enrollment share among volume-matched conditions near Primary Neoplasm

Primary Neoplasm has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Primary Neoplasm on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Primary Neoplasm is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Primary Neoplasm records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Risk-based, escalating levels of co-management Other
1 trials
Risk-based, escalating levels of monitoring Other
1 trials
Risk-based, escalating levels of care Other
1 trials
Postoperative risk stratification Other
1 trials
Preoperative risk stratification Other
1 trials

US sites by state

Facility locations filed on Primary Neoplasm trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Primary Neoplasm page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Primary Neoplasm trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Fox Chase Cancer Center sponsors the most Primary Neoplasm trials on record, review their full trial history before evaluating a specific study. See Fox Chase Cancer Center's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Primary Neoplasm condition card totals 1 registered trials; most-linked intervention Risk-based, escalating levels of co-management; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.